NielsenIQ (NIQ) (NYSE: NIQ), a leader in consumer intelligence, announced the launch of its enhanced FMCG E-commerce ...
If fenebrutinib got the FDA go-ahead, it would become the first BTK inhibitor to gain approval in both RMS and PPMS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback